Klaria Pharma (Sweden) Probability of Future Stock Price Finishing Over 0.51
| KLAR Stock | SEK 0.45 0.03 6.25% |
Klaria |
Klaria Pharma Target Price Odds to finish over 0.51
The tendency of Klaria Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 0.51 or more in 90 days |
| 0.45 | 90 days | 0.51 | about 77.34 |
Based on a normal probability distribution, the odds of Klaria Pharma to move over kr 0.51 or more in 90 days from now is about 77.34 (This Klaria Pharma Holding probability density function shows the probability of Klaria Stock to fall within a particular range of prices over 90 days) . Probability of Klaria Pharma Holding price to stay between its current price of kr 0.45 and kr 0.51 at the end of the 90-day period is about 12.1 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.1 . This indicates Klaria Pharma Holding market returns are related to returns on the market. As the market goes up or down, Klaria Pharma is expected to follow. Additionally Klaria Pharma Holding has an alpha of 0.2242, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Klaria Pharma Price Density |
| Price |
Predictive Modules for Klaria Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Klaria Pharma Holding. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Klaria Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Klaria Pharma is not an exception. The market had few large corrections towards the Klaria Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Klaria Pharma Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Klaria Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 1.10 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | 0.03 |
Klaria Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Klaria Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Klaria Pharma Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Klaria Pharma had very high historical volatility over the last 90 days | |
| Klaria Pharma has some characteristics of a very speculative penny stock | |
| Klaria Pharma Holding has accumulated 1.02 M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M. | |
| Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Klaria Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Klaria Stock often depends not only on the future outlook of the current and potential Klaria Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Klaria Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.8 M | |
| Cash And Short Term Investments | 25.5 M |
Klaria Pharma Technical Analysis
Klaria Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Klaria Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Klaria Pharma Holding. In general, you should focus on analyzing Klaria Stock price patterns and their correlations with different microeconomic environments and drivers.
Klaria Pharma Predictive Forecast Models
Klaria Pharma's time-series forecasting models is one of many Klaria Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Klaria Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Klaria Pharma Holding
Checking the ongoing alerts about Klaria Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Klaria Pharma Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Klaria Pharma had very high historical volatility over the last 90 days | |
| Klaria Pharma has some characteristics of a very speculative penny stock | |
| Klaria Pharma Holding has accumulated 1.02 M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M. | |
| Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.